IFAM
ATRA icon

Institutional & Family Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Institutional & Family Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2
Closed -$1K – 836
2020
Q1 		$1K Hold
2
– – ﹤0.01% 702
2019
Q4 		$1K Hold
2
– – ﹤0.01% 790
2019
Q3 		$1K Hold
2
– – ﹤0.01% 764
2019
Q2 		$1K Hold
2
– – ﹤0.01% 783
2019
Q1 		$2K Hold
2
– – ﹤0.01% 692
2018
Q4 		$2K Hold
2
– – ﹤0.01% 668
2018
Q3 		$3K Hold
2
– – ﹤0.01% 663
2018
Q2 		$2K Hold
2
– – ﹤0.01% 700
2018
Q1 		$2K Buy
+2
New +$1.82K ﹤0.01% 698

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Institutional & Family Asset Management's ATRA Position: Q2 2020 in Review

Institutional & Family Asset Management sold out of Atara Biotherapeutics (ATRA) in Q2 2020, closing a stake of 2 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in ATRA in Q1 2018 and held it in 9 quarters. The position peaked at $3K in Q3 2018. 122 funds tracked by Wall St. Rank hold ATRA as of Q2 2020.

  • Institutional & Family Asset Management reported no remaining Atara Biotherapeutics position as of Q2 2020 after selling out during the quarter.
  • Institutional & Family Asset Management sold 2 Atara Biotherapeutics shares in Q2 2020, an estimated $1K.
  • Institutional & Family Asset Management first reported a position in Atara Biotherapeutics in Q1 2018 and held it in 9 quarters.
  • Institutional & Family Asset Management's Atara Biotherapeutics position peaked at $3K in Q3 2018.
  • 122 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2020.

Based on Institutional & Family Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.